Literature DB >> 15178346

Progesterone receptor gene inactivation and CpG island hypermethylation in human leukemia cancer cells.

Ze-Jun Liu1, Xiao-Bing Zhang, Yun Zhang, Xin Yang.   

Abstract

Previous studies showed that progesterone receptor (PR), one of the hormone receptor superfamily, was only connected with the sex-correlated cancers such as breast cancer, endometrial cancer, prostate cancer, etc. This article deals with the PR gene in leukemia. We investigated the methylation status and the expression of the two different PR isoforms, PRA and PRB, in three leukemia cancer cell lines using methylation-specific polymerase chain reaction (MSP-PCR) and reverse transcription-PCR. The correlation of PR methylation and expression together with DNA methyltransferase (DNMT1) was further studied. We found that DNMT1 is required to maintain CpG methylation and aberrant gene silencing of PR gene in human leukemia cancer cells. The activity of 5-aza-2'-deoxycytidine in demethylation and gene reactivation may be through depleting cellular DNMT1 levels. In addition, extensive methylation of PRA and PRB was also observed in leukemia samples. Our results suggest that PR CpG island aberrant hypermethylation could be one molecular and genetic alteration in leukemia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15178346     DOI: 10.1016/j.febslet.2004.04.044

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

Review 1.  DNA methylation: its role in cancer development and therapy.

Authors:  Carla Kurkjian; Shivaani Kummar; Anthony J Murgo
Journal:  Curr Probl Cancer       Date:  2008 Sep-Oct       Impact factor: 3.187

2.  Cytosine methylation in miR-153 gene promoters increases the expression of holocarboxylase synthetase, thereby increasing the abundance of histone H4 biotinylation marks in HEK-293 human kidney cells.

Authors:  Baolong Bao; Rocio Rodriguez-Melendez; Janos Zempleni
Journal:  J Nutr Biochem       Date:  2011-07-20       Impact factor: 6.048

3.  Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse.

Authors:  Heike Kroeger; Jaroslav Jelinek; Marcos R H Estécio; Rong He; Kimie Kondo; Woonbok Chung; Li Zhang; Lanlan Shen; Hagop M Kantarjian; Carlos E Bueso-Ramos; Jean-Pierre J Issa
Journal:  Blood       Date:  2008-06-03       Impact factor: 22.113

4.  The human progesterone receptor shows evidence of adaptive evolution associated with its ability to act as a transcription factor.

Authors:  Caoyi Chen; Juan C Opazo; Offer Erez; Monica Uddin; Joaquin Santolaya-Forgas; Morris Goodman; Lawrence I Grossman; Roberto Romero; Derek E Wildman
Journal:  Mol Phylogenet Evol       Date:  2008-02-01       Impact factor: 4.286

5.  Biotinylation of histones represses transposable elements in human and mouse cells and cell lines and in Drosophila melanogaster.

Authors:  Yap Ching Chew; John T West; Stephanie J Kratzer; Anne M Ilvarsonn; Joel C Eissenberg; Bhavana J Dave; David Klinkebiel; Judith K Christman; Janos Zempleni
Journal:  J Nutr       Date:  2008-12       Impact factor: 4.798

6.  DNMT1 and DNMT3B gene variants and their association with endometriosis in South Indian women.

Authors:  K V Veena; Swapna Siddamalla; Mamata Deenadayal; Sisinthy Shivaji; Manjula Bhanoori
Journal:  Mol Biol Rep       Date:  2021-10-25       Impact factor: 2.316

7.  Mechanisms of resistance to decitabine in the myelodysplastic syndrome.

Authors:  Taichun Qin; Ryan Castoro; Samih El Ahdab; Jaroslav Jelinek; Xiaodan Wang; Jiali Si; Jingmin Shu; Rong He; Nianxiang Zhang; Woonbok Chung; Hagop M Kantarjian; Jean-Pierre J Issa
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

8.  Characterisation of the GRAF gene promoter and its methylation in patients with acute myeloid leukaemia and myelodysplastic syndrome.

Authors:  S E Bojesen; O Ammerpohl; A Weinhäusl; O A Haas; H Mettal; R M Bohle; A Borkhardt; U Fuchs
Journal:  Br J Cancer       Date:  2006-01-30       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.